Dan Burgess is the founder of Pulmocide. Pulmocide has raised $122M in total funding. Latest round: Series C.
Dan Burgess is Chairman and CEO of Pulmocide, an antibiotic company focused on respiratory diseases. Before Pulmocide, he was the Founder, President, and CEO of Rempex Pharmaceuticals, Inc. and Mpex Pharmaceuticals, Inc., both of which developed successful antibiotic treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library